581402-U
Ascentis® C8 (3 µm) HPLC Columns
L × I.D. 15 cm × 2.1 mm, HPLC Column
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Código UNSPSC:
41115700
eCl@ss:
32110501
NACRES:
SB.52
Produtos recomendados
product name
Ascentis® C8 HPLC Column, 3 μm particle size, L × I.D. 15 cm × 2.1 mm
Materiais
stainless steel column
Nível de qualidade
Agency
suitable for USP L7
linha de produto
Ascentis®
Características
endcapped
fabricante/nome comercial
Ascentis®
embalagem
1 ea of
Extensão da rotulagem
15% Carbon loading
Parâmetros
≤70 °C temp. range
400 bar pressure (5801 psi)
técnica(s)
HPLC: suitable
LC/MS: suitable
C × D.I.
15 cm × 2.1 mm
área da superfície
450 m2/g
cobertura de superfície
4.0 μmol/m2
Impurezas
<5 ppm metals
matriz
fully porous particle
silica gel high purity, spherical
Grupo ativo da matriz
C8 (octyl) phase
tamanho de partícula
3 μm
tamanho de poro
100 Å
operating pH range
2-8
aplicação(ões)
food and beverages
técnica de separação
reversed phase
Procurando produtos similares? Visita Guia de comparação de produtos
Descrição geral
The Ascentis family of columns is the fourth generation of HPLC column technology from Supelco scientists. Ascentis columns are bonded on high purity, 100 Angstrom silica including 3, 5, and 10 micron particle size. Columns are designed for small molecule applications and are scalable from micro columns (1.0 mm I.D.) to preparative dimensions (50 mm I.D.). The family includes C18, C8, Phenyl, Si and embedded polar group phase, RP-Amide.
The Ascentis C8 is a highly reproducible column with excellent selectivity towards polar compounds. The phase excells in highly aqueous mobile phases as well as high organic mobile phases.
The Ascentis C8 is a highly reproducible column with excellent selectivity towards polar compounds. The phase excells in highly aqueous mobile phases as well as high organic mobile phases.
Características e benefícios
- Superior retention for hydrophobic molecules
- Excellent peak shape
- Low bleed LC-MS separations
Informações legais
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
produto relacionado
Nº do produto
Descrição
Preços
Escolha uma das versões mais recentes:
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Mahmoud Hasan et al.
Journal of pharmaceutical and biomedical analysis, 100, 341-347 (2014-09-10)
Clodronate belongs to the class of bisphosphonates which are used for the treatment of bone disorders. Due to its high polarity it has a low and highly variable oral bioavailability which results in low plasma concentrations and requires sensitive bioanalytical
Ebenezer B Asafu-Adjaye et al.
Journal of pharmaceutical and biomedical analysis, 43(5), 1854-1859 (2007-02-16)
Gastrointestinal stability of venlafaxine was evaluated in vitro in simulated gastric (SGF) and intestinal (SIF) fluids using a stability indicating HPLC method. The method was validated using a 5 microm Ascentis C18 column (150 mm x 4.6 mm) and mobile
Luana Magalhães et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1008, 98-107 (2015-12-08)
Nucleoside triphosphate diphosphohydrolase (NTPDase) is an enzyme belonging to the apyrase family that participates in the hydrolysis of the nucleosides di- and triphosphate to the corresponding nucleoside monophosphate. This enzyme underlies the virulence of parasites such as Leishmania. Recently, an
Ugandar Reddy Inugala et al.
Journal of chromatographic science, 51(5), 453-459 (2012-10-13)
This paper describes the development of a rapid, novel, stability-indicating gradient reversed-phase high-performance liquid chromatographic method and associated system suitability parameters for the analysis of naproxcinod in the presence of its related substances and degradents using a quality-by-design approach. All
Sreenivasa Rao Chitturi et al.
Journal of pharmaceutical and biomedical analysis, 55(1), 31-47 (2011-02-15)
This paper proposes a simple and selective RP-HPLC method for the determination of process impurities and degradation products (degradants) of atazanavir sulfate (ATV) drug substance. Chromatographic separation was achieved on Ascentis(®) Express C8, (150mm×4.6mm, 2.7μm) column thermostated at 30°C under
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica